Ireland

--:--IST

Latest

Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide

Subscribe

Registers› Irish medicines ›Ondansetron

Medicines register · Ireland

Ondansetron — medicines in Ireland

24 authorised products containing Ondansetron, from the HPRA register.

Source: HPRA open dataset ("Authorised or Transfer Pending Products"), CC BY 4.0. Complete coverage — all 10,296 authorised products are in this register. Synced 07 Oct 2026, 03:23 UTC

Narrow the register Reset

Search within results

Matches brand name, active substance, licence holder and licence number.

Browse by first letter

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9

Medicine

Active substance

Licence holder

Status

Emizof 4 mg film-coated tablets PA23266/041/001

Ondansetron

Viatris Limited

Marketed

Emizof 8 mg film-coated tablets PA23266/041/002

Ondansetron

Viatris Limited

Marketed

Ondansetron 2 mg/ml Solution for Injection PA1122/004/001

Ondansetron

Noridem Enterprises Limited

Marketed

Ondansetron 2 mg/ml Solution for Injection or Infusion PA23266/040/001

Ondansetron

Viatris Limited

Marketed

Ondansetron 2 mg/ml Solution for Injection or Infusion PA2315/168/001

Ondansetron

Accord Healthcare Ireland Ltd.

Marketed

Ondansetron 2 mg/ml solution for injection/infusion PA2165/013/001

Ondansetron

Marketed

Ondansetron 2mg/ml Solution for Injection PA2299/037/001

Ondansetron

Baxter Holding B.V.

Marketed

Ondansetron 4 mg film-coated tablets PA0749/009/001

Ondansetron

Teva Pharma B.V.

Marketed

Ondansetron 4 mg/5 ml syrup PA22697/013/001

Ondansetron

Syri Pharma Limited t/a Thame Laboratories

Marketed

Ondansetron 8 mg film-coated tablets PA0749/009/002

Ondansetron

Teva Pharma B.V.

Marketed

Ondansetron Kabi 2 mg/ml solution for injection PA2059/048/001

Ondansetron

Fresenius Kabi Deutschland GmbH

Marketed

Ondran 4 mg film-coated tablets PA0281/127/001

Ondansetron

Pinewood Laboratories Ltd

Marketed

Ondran 8 mg film-coated tablets PA0281/127/002

Ondansetron

Pinewood Laboratories Ltd

Marketed

Zofran 4 mg film-coated tablets PA0711/327/003

Ondansetron

Marketed

Zofran 4 mg film-coated tablets PPA0465/113/001

Ondansetron

PCO Manufacturing Ltd.

—

Zofran 4 mg film-coated tablets PPA1463/158/002

Ondansetron

IMED Healthcare Ltd.

—

Zofran 4 mg/5 ml syrup PA0711/327/002

Ondansetron

Marketed

Zofran 8 mg film-coated tablets PA0711/327/004

Ondansetron

Marketed

Zofran 8 mg film-coated tablets PPA0465/113/002

Ondansetron

PCO Manufacturing Ltd.

—

Zofran 8 mg film-coated tablets PPA1463/158/003

Ondansetron

IMED Healthcare Ltd.

—

Zofran Zydis 4 mg oral lyophilisate PA0711/327/005

Ondansetron

Marketed

Zofran Zydis 4 mg oral lyophilisate PPA2306/006/001

Ondansetron

Originalis B.V.

—

Zofran Zydis 4 mg oral lyophilisate PPA0465/445/001

Ondansetron

PCO Manufacturing Ltd.

—

Zofran Zydis 8 mg oral lyophilisate PA0711/327/006

Ondansetron

Marketed

Cite this view

Priya Life Science (2026). Irish Medicines Register, filtered. Derived from the HPRA open dataset. Retrieved 7 October 2026. https://priyalifescience.com/medicines/substance/ondansetron

Download this register

GET /api/export.php?register=medicines-ie&format=csv Try the JSON export →

Regulatory information only — not medical advice. For the authoritative record see the HPRA register directly.